Literature DB >> 9741567

Primary pulmonary hypertension: insights into pathogenesis from epidemiology.

N Galiè1, A Manes, L Uguccioni, F Serafini, M De Rosa, A Branzi, B Magnani.   

Abstract

Primary pulmonary hypertension (PPH) is a rare disease that affects young people predominantly of female gender. Early epidemiologic studies have shown that the diagnosis is usually made 1 to 2 years after symptoms onset, and the mean survival is reduced to 2 to 3 years thereafter. New insights into the pathogenesis of PPH by epidemiologic studies may be obtained through the utilization of informatic technologies coupled to a clear definition of the disease. Early stages of precapillary pulmonary hypertension could be identified through screening tests like echocardiography in populations with higher incidence, such as familial PPH and the conditions associated with pulmonary hypertension. These latter conditions are hemodynamically and pathologically similar to the primary form, and they can give insight into several possible aspects of the pathogenesis of PPH. Prospective registries are very useful in coordinating the collection of epidemiologic data, and new technologies, such as informatics, may improve the management and the continuous updating of the databases.

Entities:  

Mesh:

Year:  1998        PMID: 9741567     DOI: 10.1378/chest.114.3_supplement.184s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Increased right ventricular Septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass.

Authors:  Jens Vogel-Claussen; Monda L Shehata; Dirk Lossnitzer; Jan Skrok; Sukhminder Singh; Danielle Boyce; Noah Lechtzin; Reda E Girgis; Stephen C Mathai; Joao A Lima; David A Bluemke; Paul M Hassoun
Journal:  Invest Radiol       Date:  2011-09       Impact factor: 6.016

2.  Tissue Doppler imaging predicts adverse outcome in children with idiopathic pulmonary arterial hypertension.

Authors:  Shinichi Takatsuki; Tomotaka Nakayama; Pei-Ni Jone; Brandie D Wagner; Kazuyuki Naoi; D Dunbar Ivy; Tsutomu Saji
Journal:  J Pediatr       Date:  2012-06-28       Impact factor: 4.406

3.  Eisenmenger syndrome and atrial septal defect: nature or nurture?

Authors:  Judith Therrien; Sherryn Rambihar; Bill Newman; Kathy Siminovitch; David Langleben; Gary Webb; John Granton
Journal:  Can J Cardiol       Date:  2006-11       Impact factor: 5.223

Review 4.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

5.  Pulmonary hypertension in children and adolescents with sickle cell disease.

Authors:  O C Onyekwere; A Campbell; M Teshome; S Onyeagoro; C Sylvan; A Akintilo; S Hutchinson; G Ensing; P Gaskin; G Kato; S Rana; J Kwagyan; V Gordeuk; J Williams; O Castro
Journal:  Pediatr Cardiol       Date:  2007-08-07       Impact factor: 1.655

6.  Integrated care and optimal management of pulmonary arterial hypertension.

Authors:  Geoff Strange; Robin Fowler; Corina Jary; Brad Dalton; Simon Stewart; Eli Gabbay
Journal:  J Multidiscip Healthc       Date:  2009-05-12

Review 7.  Sildenafil in the treatment of pulmonary hypertension.

Authors:  Christopher F Barnett; Roberto F Machado
Journal:  Vasc Health Risk Manag       Date:  2006

8.  Pulmonary Arterial Hypertension in Patients with Primary Sjögren's Syndrome.

Authors:  Senol Kobak; Sezai Kalkan; Bahadır Kirilmaz; Mehmet Orman; Ertuğurul Ercan
Journal:  Autoimmune Dis       Date:  2014-01-09

9.  Pulmonary Arterial Hypertension and Insulin Resistance.

Authors:  Elisa A Bradley; David Bradley
Journal:  J Mol Genet Med       Date:  2014-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.